• Bill Would Restrict Co-Pays, Other Cost-Sharing Measures

    • 20 March 2012
    Co-pays, cost-sharing, coinsurance and other methods used by pharmaceutical companies as an incentive for patients to purchase their drugs would be restricted under a new bipartisan bill introduced in the House of Representatives on 19 March. H.R. 4209 - Patient's Access to Treatments Act of 2012 , introduced by Reps. David McKinley (R-WV), Lois Capps (D-CA), Barney Frank (D-MA), Henry Cuellar (D-TX) and C.W. Bill Young (R-FL), would do away with preferential treatmen...